Ezra Frech, Team Sanofi Athlete

Ezra Frech, Team Sanofi Athlete

Ezra Frech, Team Sanofi Athlete

We Never Settle

Celebrating Team Sanofi athletes and Sanofians on the road to Paris 2024 Olympic and Paralympic Games.

Our Latest News

Social Impact

June 20, 2024

Childhood Cancer R&D Program: Developing and Accelerating Novel Therapies for Children With Cancer

Shuang Yang, Scientist, China

Second quarter 2024 results

Second quarter 2024 results will be reviewed by management during a live audio webcast with the financial community on July 25th, 2024. The presentation will be followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EST)

United by Purpose

Each of us plays a unique role in bringing our purpose to life.

Sanofi X Paris 2024

We’re proud to be premium partner of Paris 2024.

Science and sport aren’t that different. Just like athletes do, we overcome setbacks to keep moving forward, not just for ourselves, but for our patients, colleagues, families and friends.

About Us

Who We Are

We are an innovative global healthcare company.

Our Pipeline

5

Therapeutic areas

77

Compounds in clinical development

28

Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases

June 25, 2024
Media Update: Riliprubart one-year follow-up from phase 2 study underpin the potential as a first-in-class treatment in chronic inflammatory demyelinating polyneuropathy
June 25, 2024
Press Release: Availability of the Q2 2024 Aide-mémoire
June 21, 2024
Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee
June 21, 2024
Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran